A phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU [fluorouracil] combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma.

Trial Profile

A phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU [fluorouracil] combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Oct 2016

At a glance

  • Drugs Interferon alpha-2b (Primary) ; Cisplatin; Fluorouracil; Folinic acid
  • Indications Pancreatic cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms CapRI
  • Most Recent Events

    • 24 Sep 2012 Results published in the Journal of Clinical Oncology.
    • 07 Jun 2010 Primary endpoint 'Overall-survival-duration' has not been met.
    • 07 Jun 2010 Results were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top